pembrolizumab
merck,medsir
['keynote-522', 'tnbc', 'key,note,52', 'pembro', 'medsir']
#rebeccadent presented nice and important results showing that besides clinical benefit, neoadj pembro+ct followed by adj pembro in early-stage tnbc pts does not affect quality of life of treated pts -phase iii keynote-522-.
#esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM